Evaluation of NID2 promoter methylation for screening of Oral squamous cell carcinoma

BACKGROUND: Oral squamous cell carcinoma (OSCC) is an aggressive human malignancy. Because of late diagnosis and recurrence of OSCC, the treatment of patients with OSCC is often ineffective. Thus, finding novel biomarkers of OSCC are essential. Here we derived a methylation marker by utilizing methy...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Cancer
Autors principals: Srisuttee, Ratakorn, Arayataweegool, Areeya, Mahattanasakul, Patnarin, Tangjaturonrasme, Napadon, Kerekhanjanarong, Virachai, Keelawat, Somboon, Mutirangura, Apiwat, Kitkumthorn, Nakarin
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2020
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7071563/
https://ncbi.nlm.nih.gov/pubmed/32171289
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-020-6692-z
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars